a case of unsteadiness and limb weakness
DESCRIPTION
A Interesting Case ReportTRANSCRIPT
A Case of Unsteadiness and Limb Weakness
Dr Richard McCrory
CT2 Medicine
9th March 2011
Case Presentation: Mrs E.W. (1)
Previously fit and well 73 year old lady• Right Handed• Independently Mobile
Admitted from A&E Mater Hospital 27/8/2010
PC: 1 week history of dizziness, “clumsiness” (especially with the left hand) and unsteadiness on her feet.
Referral to A&E prompted by two falls in preceding 24 hours when trying to walk
Mrs E.W. (2)
PMHx:Hypertension (on Ramipril 2.5mg)Non-smoker, No alcoholElevated cholesterol (on Simvastatin 40mg)No recent head injury / traumaNo family history of neurological disorders
Systematic Enquiry:Collateral history suggested episodic
forgetfulness past 2 months, occasionally withdrawn and dropped crockery at home.
Initial assessment 27/8/10
CVS: Pulse 80 regular, BP 139/74 2HS no murmurs, no bruits, no postural BP drop
RS: Chest clearAbdomen: NAD
Neurological ExamDysarthric, slight loss nasolabial fold on leftPronator drift left arm, hypotoniaPower LUL 4+/5 LLL4+/5, mild truncal ataxiaImpaired co-ordination on left sideNo visual field defect, coarse nystagmus on
leftward gazeAbbreviated Mental Test - 8/10
Initial Investigations
ECG – Normal Sinus Rhythm
Bloods – All within normal range, ESR normal, TFT’s normal
CXR – Heart size normal, no lung field abnormalities
CT Brain (29/08/10)
Chronic Ischaemic Periventicular and deep white matter changes, no acute infarct seen. No bleed visible.
Initial Clinical Diagnosis - Left Cerebellar Stroke
Aspirin 300mg for 2/52
MRI Brain + Angiogram booked for assessment of posterior circulation
Trans-thoracic Echocardiogram – Normal structure and function, Normal Valves
Seen by PT/OT
Berg Score 30/8/10 – 32/56
Limited safety awareness, mobilised with assistance of 1 + ZF
But there’s more…
Week 2 of admission:
Limited progress with Physio/OT
Unsteady on feet
Apathetic / Withdrawn – started on SSRI
Safety awareness problematic, several IR1 forms re. falls at bedside, poor retention of information, tended to move unsupervised. MMSE 21/30
Week 3Choking intermittently on food
• SLT recommended pureed diet
Worsening dysarthria
Power LUL 3/5 LLL 4/5
Further ischaemia queried – switched to clopidogrel
Week 4Progressing truncal and neck ataxia
Deteriorating sitting balance, standing assistance of 2
Fell out of chair 21/9/10 attempting to stand despite repeated assertions to not mobilise independently
Sustained contusion and laceration to right scalp – no loss of consciousness
Repeat Berg Score - 4/56
21/9/10 Repeat CT Brain – no interval change
30/9/10MRI Brain and Angiogram
Bilateral Periventricular IschaemiaSeveral high signal changes in cerebellar
peduncles and left medulla on T2 images‘Unusual distribution’ but could correlate
with ischaemic changesNo vessel abnormalities
Started on LMWH for posterior circulation ischaemia
But there’s (still) more…
Week 5Only safe in bedUnintelligible speechDoubly incontinentEvolving right sided cerebellar signsDeteriorating swallow – referred to dietician for NG
tube and enteral feeds, and on IV fluidsRepeat bloods – no signs of infection / inflammation
Re-evaluated initial diagnosis and differential, proceeded to Lumbar Puncture
Investigations
Lumbar Puncture (09/10/10)• Clear colourless fluid• CSF glucose – Normal• Gram Stain and Culture – Negative• Cell Count – WCC 5 cells/mm3• CSF Protein elevated: 0.79g/dl (Normal range 0.1 –
0.3 g/dl), confirmed on repeat LP
ANCA/ANA/Serum ACE / Oligolonal Bands – Negative
HSV/CMV PCR on CSF - Negative
Sought Neurology advice from RVH
Advised
Check Anti-Neuronal Antibodies – sent to London
Breast Exam - Normal
CT Chest / Abdomen / Pelvis to seek occult malignancy
CT Chest/Abdo/Pelvis 19/10/10
• No evidence of mediastinal or para-aortic lymphadenopathy
• Lung fields and visceral organs appeared normal
• However a 2.5 x 1.7 cm soft tissue mass was identified in the right breast.• Plans made for transfer to BCH breast clinic for
triple assessment
• Became unwell with Tachycardia, Tachypnoea
• CXR noted new pulmonary filling defects consistent with consolidation
• Started Tazocin• Blood cultures positive for Methicillin
Sensitive Staph Aureus• Possible venflon associated infection• Switched to Vancomycin / Meropenem
Final Diagnosis –
Paraneoplastic Cerebellar Degeneration secondary to Primary B-Cell Lymphoma of the Breast
The Cerebellum – A Brief Overview of Functional Anatomy
• Archicerebellum – maintenance of equilibrium
• Paleocerebellum – muscle tone and posture
• Neocerebellum – muscular co-ordination
Paraneoplastic Neurological Syndromes
‘A humoral or immune-mediated mechanism other than a metastatic complication in patients with an underlying malignancy.’
‘Remote effect’ immune mediated CNS pathology affects 1-3% of all cancer patients.
Paraneoplastic cerebellar degeneration (PCD)
• Constitutes 25-35% of paraneoplastic neurologic syndromes diagnosed.
• Characterised by diffuse loss of Purkinje cells throughout the cerebellar cortex.
• Antibodies directed to Purkinje cytoplasmic and nuclear proteins regulating cell survival trigger apoptosis• Anti-Yo, Anti-Tr, Anti-Hu plus others• 40% no recognisable antibody identified
• In 60–70% of patients, neurological symptoms precede diagnosis of the cancer by a few months to 2–3 years.
Common Neoplasms associated with PCD• Breast and Ovary (Anti-Yo)• Small Cell Lung Cancer (Anti-Hu, Anti-Ri)• Lymphoma (Anti-Tr highly specific)
Clinical Features of PCD
• Mild unilateral cerebellar signs evolving (days-weeks) into severe bilateral cerebellar dysfunction, then symptoms stabilise with profound physical disability.• Mild cognitive deficits as well as
affective symptoms seen in 20% of cases (Cerebellar Cognitive Affective Syndrome)
A Large Diagnostic Differential
Cerebrovascular• Ischaemic or Haemorrhagic Stroke
Toxins• Alcohol / Chemotherapy / Anticonvulsants
Inflammatory Disorders• Multiple Sclerosis / Neurosarcoidosis
Encephalomyelitis
Intracranial Neoplasm• Primary CNS / Metastatic / Leptomeningeal
Neurodegenerative Disorders• Spinocerebellar Ataxia (Sporadic)• Prion Related Diseases
Findings not Consistent with paraneoplastic cerebellar degeneration
Include the following:• Severely altered mental status with
myoclonus and ataxia• Predominantly corticospinal tract
dysfunction• Unilateral cerebellar dysfunction• Familial cerebellar degeneration
Investigations
CT / MRI Brain may be initially normal
Cerebellar atrophy more pronounced in latter stages of disease
Lumbar Puncture
High CSF protein, Pleocytosis
Can identify auto-antibodies in CSF and help exclude leptomeningeal disease
CT / PET to look for occult malignancy
Treatment
Variable but generally unsatisfactory• Complete and Partial remission
possible but uncommon
Approach 1Remove antigen source (Tumour)
Surgery, Chemoradiotherapy as applicable
Approach 2 Suppress immune response
Steroids, Cyclophospamide, Rituximab
Prognosis
Commonly disability correlates with onset of treatment – ‘The Horse has bolted’
May require extended follow-up if occult malignancy suspected
Oncologic outcome of patients with antibody-associated paraneoplastic syndromes does not significantly differ from that of patients without syndrome.
Take Home Messages
• Consider a diagnosis of PCD in patients who present with acute or subacute cerebellar degeneration and no risk factors for cerebellar disorders
• Identification of specific auto-antibodies may help guide diagnostic assessment